Emergence and evolution of TP53 mutations are a key feature of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.

Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

Cited literature [15 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01691580
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, January 24, 2018 - 10:27:26 AM
Last modification on : Wednesday, November 6, 2019 - 9:42:24 AM

File

haematol.2017Eq10.pdf
Files produced by the author(s)

Identifiers

Citation

Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, et al.. Emergence and evolution of TP53 mutations are a key feature of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.. Haematologica, Ferrata Storti Foundation, 2018, Epub ahead of print. ⟨10.3324/haematol.2017.181404⟩. ⟨inserm-01691580⟩

Share

Metrics

Record views

295

Files downloads

269